109 related articles for article (PubMed ID: 10229625)
1. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
Jullian N; Brabet I; Pin JP; Acher FC
J Med Chem; 1999 May; 42(9):1546-55. PubMed ID: 10229625
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.
Costantino G; Pellicciari R
J Med Chem; 1996 Sep; 39(20):3998-4006. PubMed ID: 8831765
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore models of group I and group II metabotropic glutamate receptor agonists. Analysis of conformational, steric, and topological parameters affecting potency and selectivity.
Costantino G; Macchiarulo A; Pellicciari R
J Med Chem; 1999 Jul; 42(15):2816-27. PubMed ID: 10425091
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
6. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
[TBL] [Abstract][Full Text] [Related]
7. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
Fraley ME
Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
[TBL] [Abstract][Full Text] [Related]
8. Partial agonists and subunit selectivity at NMDA receptors.
Risgaard R; Hansen KB; Clausen RP
Chemistry; 2010 Dec; 16(47):13910-8. PubMed ID: 20945316
[TBL] [Abstract][Full Text] [Related]
9. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
[TBL] [Abstract][Full Text] [Related]
10. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative modulation of group I metabotropic glutamate receptors.
Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
[TBL] [Abstract][Full Text] [Related]
13. Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site.
Bessis AS; Jullian N; Coudert E; Pin JP; Acher F
Neuropharmacology; 1999 Oct; 38(10):1543-51. PubMed ID: 10530816
[TBL] [Abstract][Full Text] [Related]
14. A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
Selvam C; Oueslati N; Lemasson IA; Brabet I; Rigault D; Courtiol T; Cesarini S; Triballeau N; Bertrand HO; Goudet C; Pin JP; Acher FC
J Med Chem; 2010 Apr; 53(7):2797-813. PubMed ID: 20218620
[TBL] [Abstract][Full Text] [Related]
15. Domains determining ligand specificity for Ca2+ receptors.
Hammerland LG; Krapcho KJ; Garrett JE; Alasti N; Hung BC; Simin RT; Levinthal C; Nemeth EF; Fuller FH
Mol Pharmacol; 1999 Apr; 55(4):642-8. PubMed ID: 10101021
[TBL] [Abstract][Full Text] [Related]
16. Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1.
Kohara A; Toya T; Tamura S; Watabiki T; Nagakura Y; Shitaka Y; Hayashibe S; Kawabata S; Okada M
J Pharmacol Exp Ther; 2005 Oct; 315(1):163-9. PubMed ID: 15976016
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
[TBL] [Abstract][Full Text] [Related]
18. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
Ossowska K; Konieczny J; Wardas J; Pietraszek M; Kuter K; Wolfarth S; Pilc A
Amino Acids; 2007 Feb; 32(2):179-88. PubMed ID: 16699817
[TBL] [Abstract][Full Text] [Related]
19. Ion dependence of ligand binding to metabotropic glutamate receptors.
Kuang D; Hampson DR
Biochem Biophys Res Commun; 2006 Jun; 345(1):1-6. PubMed ID: 16674916
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.
Schann S; Menet C; Arvault P; Mercier G; Frauli M; Mayer S; Hubert N; Triballeau N; Bertrand HO; Acher F; Neuville P
Bioorg Med Chem Lett; 2006 Sep; 16(18):4856-60. PubMed ID: 16828551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
